Astrazeneca Canada Inc. v. Apotex Inc.

Drug: omeprazole

The Court heard the dispute between the parties as to whether certain amendments to the amended Statement of Defence and Counterclaim should be allowed. The Court allowed pleadings relating to a Korean action recited in U.S. decisions that the Plaintiffs put in play. However, pleadings requesting discovery relating to litigation in other foreign countries, pleadings alleging that as the plaintiffs did not assert claims in the United States, they could not assert them in Canada, and pleadings alleging estoppel based on alleged contrary statements made by the Plaintiffs in the United States and Korean proceedings against other parties were not allowed.